Tatsis Ourania's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 28, 2022
- Accession no.
- 0000899243-22-008123
- Filed
- Feb 28, 2022
- Trade date
- Feb 24-25, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $75.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tatsis OuraniaCIK 0001789815 | Officer (EVP, Chief Reg. & Quality Off.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2022 | Common Stock | FTax withholdingDisposed | −2,590 | $227.86 | −$590,157.4 | 50,514 | Direct | |
| Feb 25, 2022 | Common Stock | SSaleDisposed | −28 | $228.88F2,F3 | −$6,408.64 | 50,486 | Direct | |
| Feb 25, 2022 | Common Stock | SSaleDisposed | −77 | $230.26F3,F4 | −$17,730.02 | 50,409 | Direct | |
| Feb 25, 2022 | Common Stock | SSaleDisposed | −115 | $230.97F3,F5 | −$26,561.55 | 50,294 | Direct | |
| Feb 25, 2022 | Common Stock | SSaleDisposed | −87 | $231.81F3,F6 | −$20,167.47 | 50,207 | Direct | |
| Feb 25, 2022 | Common Stock | SSaleDisposed | −18 | $232.80F3,F7 | −$4,190.4 | 50,189 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Open market sales reported on this line occurred at a weighted average price of $228.88 (range $228.39 to $229.36).
Referenced by the price of 1 transaction in Table I.
- F3
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $230.26 (range $229.50 to $230.48).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $230.97 (range $230.50 to $231.47).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $231.81 (range $231.52 to $232.31).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $232.80 (range $232.59 to $232.92).
Referenced by the price of 1 transaction in Table I.